A Phase 2A Partially-Blind Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Live Attenuated, Intranasal B. Pertussis Vaccine (BPZE1) in Healthy Adults
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2019
At a glance
- Drugs BPZE 1 (Primary)
- Indications Pertussis
- Focus Adverse reactions
- 20 Sep 2018 Status changed from not yet recruiting to recruiting.
- 06 Sep 2018 Planned initiation date changed from 30 Aug 2018 to 20 Sep 2018.
- 16 Aug 2018 Planned initiation date changed from 3 Aug 2018 to 30 Aug 2018.